Literature DB >> 10691858

Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions.

Y T Liu1, J M Old, K Miles, C A Fisher, D J Weatherall, J B Clegg.   

Abstract

We describe a sensitive, reliable and reproducible method, based on three multiplex PCR assays, for the rapid detection of seven common alpha-thalassaemia deletions and one alpha-globin gene triplication. The new assay detects the alpha0 deletions - -SEA, - (alpha)20.5, - -MED, - -FIL and - -THAI in the first multiplex PCR, the second multiplex detects the -alpha3.7 deletion and alphaalphaalphaanti3.7 variant, the third multiplex detects the -alpha4.2 deletion. This simple multiplex method should greatly facilitate the genetic screening and molecular diagnosis of these determinants in populations where alpha-thalassaemias are prevalent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691858     DOI: 10.1046/j.1365-2141.2000.01870.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  69 in total

1.  Alpha0 thalassaemia as a result of a novel 11.1 kb deletion eliminating both of the duplicated alpha globin genes.

Authors:  S-Q Jia; J Li; Q-H Mo; C Liao; L-Y Li; X-M Xu
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

2.  Rapid, accurate genotyping of the common -alpha(4.2) thalassaemia deletion based on the use of denaturing HPLC.

Authors:  H Ou-Yang; L Hua; Q H Mo; X M Xu
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

3.  The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening.

Authors:  X M Xu; Y Q Zhou; G X Luo; C Liao; M Zhou; P Y Chen; J P Lu; S Q Jia; G F Xiao; X Shen; J Li; H P Chen; Y Y Xia; Y X Wen; Q H Mo; W D Li; Y Y Li; L W Zhuo; Z Q Wang; Y J Chen; C H Qin; M Zhong
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

4.  Refinement of the genetic cause of ATR-16.

Authors:  Cornelis L Harteveld; Marjolein Kriek; Emilia K Bijlsma; Zoran Erjavec; Deepak Balak; Marion Phylipsen; Astrid Voskamp; Emmanora di Capua; Stefan J White; Piero C Giordano
Journal:  Hum Genet       Date:  2007-06-28       Impact factor: 4.132

5.  Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory.

Authors:  Sumit Punj; Yassmine Akkari; Jennifer Huang; Fei Yang; Allison Creason; Christine Pak; Amiee Potter; Michael O Dorschner; Deborah A Nickerson; Peggy D Robertson; Gail P Jarvik; Laura M Amendola; Jennifer Schleit; Dana Kostiner Simpson; Alan F Rope; Jacob Reiss; Tia Kauffman; Marian J Gilmore; Patricia Himes; Benjamin Wilfond; Katrina A B Goddard; C Sue Richards
Journal:  Am J Hum Genet       Date:  2018-05-10       Impact factor: 11.025

6.  alpha-Thalassaemia in Tunisia: some epidemiological and molecular data.

Authors:  H Siala; F Ouali; T Messaoud; A Bibi; S Fattoum
Journal:  J Genet       Date:  2008-12       Impact factor: 1.166

Review 7.  Alpha-thalassaemia.

Authors:  Cornelis L Harteveld; Douglas R Higgs
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

8.  Hydrops fetalis associated with homozygosity for Hb Adana [alpha59(E8)Gly-->Asp (alpha2)].

Authors:  Ita M Nainggolan; Alida Harahap; Iswari Setianingsih
Journal:  Hemoglobin       Date:  2010       Impact factor: 0.849

9.  beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C.

Authors:  Soledad Gamarra; Guillermo Garcia-Effron; Carmen Monteserin; Isabel Lopez-Villar; Florinda Gilsanz; Joaquín Martinez-Lopez
Journal:  Adv Hematol       Date:  2009-07-28

10.  The use of real-time PCR technique in the detection of novel protein 4.2 gene mutations that coexist with thalassaemia alpha in a single patient.

Authors:  Monika Maciag; Anna Adamowicz-Salach; Alicja Siwicka; Justyna Spychalska; Beata Burzynska
Journal:  Eur J Haematol       Date:  2009-06-08       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.